» Articles » PMID: 33915827

The Side Effects of Therapeutic Radioiodine-131 on the Structure of Enamel and Dentin in Permanent Human Teeth

Overview
Journal Biology (Basel)
Publisher MDPI
Specialty Biology
Date 2021 Apr 30
PMID 33915827
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Radioiodine-131 (I-131) is an essential therapy for patients with differentiated thyroid carcinomas (DTC). Generally, I-131 is safe and well tolerated, but patients may present early or late complications in the oral and maxillofacial areas. Thus, the aim of this study was to evaluate in-vitro, the alteration of enamel and dentin after I-131 exposure using histopathological assessment, scanning electron microscopy (SEM) and atomic force microscopy (AFM). For I-131 irradiation, an in-vitro protocol was used that simulates the procedure for irradiation therapy performed for patients with DTCs. A total of 42 teeth were divided into seven groups (n = 6) and irradiated as follows: control, irradiation groups (3, 6, 12, 36, 48 h, 8 days). Histological changes were observed at 48 h (enamel surface with multifocal and irregular areas) and at 8 days (enamel surface with multiple, very deep, delimited cavities). SEM imaging revealed the enamel destruction progresses along with the treatment time increasing. The alterations are extended into the enamel depth and the dislocated hydroxyapatite debris is overwhelming. The enamel-dentine interface shows small gaps after 6 h and a very well developed valley after 12 h; the interface microstructure resulted after 8 days is deeply altered. The AFM imaging shows that I-131 affects the protein bond between hydroxyapatite nano-crystals causing loss of cohesion, which leads to significant increasing of nano-particles diameter after 6 h. In conclusion, both enamel and dentin appear to be altered between 12 and 48 h and after 8 days of treatment are extended in depth.

Citing Articles

Zirconia Implants Indicated Better Stability After Exposure to Radioiodine-131 Therapy Used for Differentiated Thyroid Cancer.

Mester A, Piciu D, Moldovan M, Sarosi C, Cuc S, Petean I Cancers (Basel). 2025; 17(4).

PMID: 40002272 PMC: 11852575. DOI: 10.3390/cancers17040678.


Assessment of oral health-related quality of life and oral side effects of radioactive iodine therapy.

Yemenoglu H, Peker K, Kose T, Gunacar D, Bulbul O Clin Oral Investig. 2025; 29(2):121.

PMID: 39920464 PMC: 11805838. DOI: 10.1007/s00784-025-06201-y.


A Comparative Analysis of Enamel Surface Roughness Following Various Interproximal Reduction Techniques: An Examination Using Scanning Electron Microscopy and Atomic Force Microscopy.

Serbanoiu D, Vartolomei A, Ghiga D, Moldovan M, Sarosi C, Petean I Biomedicines. 2024; 12(8).

PMID: 39200094 PMC: 11351462. DOI: 10.3390/biomedicines12081629.


Radioiodine-131 Therapy Used for Differentiated Thyroid Cancer Can Impair Titanium Dental Implants: An In Vitro Analysis.

Piciu D, Bran S, Moldovan M, Varvara S, Piciu A, Cuc S Cancers (Basel). 2023; 15(9).

PMID: 37174023 PMC: 10177135. DOI: 10.3390/cancers15092558.

References
1.
Sunavala-Dossabhoy G . Radioactive iodine: An unappreciated threat to salivary gland function. Oral Dis. 2018; 24(1-2):198-201. PMC: 5830132. DOI: 10.1111/odi.12774. View

2.
Palmier N, Madrid C, de Pauli Paglioni M, Rivera C, Lebre Martins B, Araujo A . Cracked tooth syndrome in irradiated patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018; 126(4):335-341.e2. DOI: 10.1016/j.oooo.2018.06.005. View

3.
Lee S, Lee J, Kim S, Han S, Bae W . Prediction of risk for symptomatic sialadenitis by post-therapeutic dual (131)I scintigraphy in patients with differentiated thyroid cancer. Ann Nucl Med. 2013; 27(8):700-9. DOI: 10.1007/s12149-013-0735-3. View

4.
BARTELSTONE H . Radioiodine penetration through intact enamel with uptake by bloodstream and thyroid gland. J Dent Res. 1951; 30(5):728-33. DOI: 10.1177/00220345510300051601. View

5.
Ross D . Radioiodine therapy for hyperthyroidism. N Engl J Med. 2011; 364(6):542-50. DOI: 10.1056/NEJMct1007101. View